Clinical Trials Browser

OTHER × Has results × Neuromyelitis Optica × Clear all

NCT02276963 2019-06-06

Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses

Phase 1 Completed

6 enrolled 9 charts

Myelitis, Transverse, Neuromyelitis Optica, Optic Neuritis

NCT02166346 2018-04-17

Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)

Phase 2 Completed

24 enrolled 10 charts

Myelitis, Myelitis, Transverse, Neuromyelitis Optica